Patent · US Active

Means and methods for the treatment of tumorous diseases

US8007796B2 · kind B2 · utility

28Cited by

1References

18Claims

0Family size

Assignee

Micromet AG · DE

Inventors

Patrick Baeuerle · Gauting, DE
Peter Kufer · Munich, DE
Matthias Klinger · Gilching, DE
Eugen Leo · Cologne, DE

Key dates

Filing date	Nov 29, 2006
Grant date	Aug 30, 2011
Priority date	—
Expiry date	Sep 28, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pharmaceutical means and methods for the prevention, treatment or amelioration of indolent or aggressive B cell non-Hodgkin lymphoma (B NHL) and B cell leukemia comprising the administration of a bispecific single chain antibody construct to a subject and the use of the bispecific single chain antibody construct for the preparation of a pharmaceutical composition for the prevention, treatment or amelioration of indolent or aggressive B cell non-Hodgkin lymphoma (B NHL) and B cell leukemia. The construct is to be administered for at least 1 week in specified daily doses. Moreover, the invention relates to kits comprising a bispecific single chain antibody construct to be used in accordance with this invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.